EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study

Miao Hui iD, Jun Ma, Hongyu Yang, Bixia Gao, Fang Wang, Jinwei Wang iD, Jicheng Lv, Luxia Zhang, Li Yang iD, Minghui Zhao

Journal of Clinical Medicine · 14.02.2023 · 12 (4) · 1504

DOI: 10.3390/jcm12041504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.02.2023. Verfasst von Miao Hui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of the Ministry of Science and Technology of China, National Natural Science Foundation of China, Chinese Scientific and Technical Innovation Project 2030.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives: In light of the growing burden of chronic kidney disease (CKD), it is of particular importance to create disease prediction models that can assist healthcare providers in identifying cases of CKD individual risk and integrate risk-based care for disease progress management. The objective of this study was to develop and validate a new pragmatic end-stage kidney disease (ESKD) risk prediction utilizing the Cox proportional hazards model (Cox) and machine learning (ML). Design, setting, participants, and measurements: The Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE), a multicenter CKD cohort in China, was employed as the model’s training and testing datasets, with a split ratio of 7:3. A cohort from Peking University First Hospital (PKUFH cohort) served as the external validation dataset. The participants’ laboratory tests in those cohorts were conducted at PKUFH. We included individuals with CKD stages 1~4 at baseline. The incidence of kidney replacement therapy (KRT) was defined as the outcome. We constructed the Peking University-CKD (PKU-CKD) risk prediction model employing the Cox and ML methods, which include extreme gradient boosting (XGBoost) and survival support vector machine (SSVM). These models discriminate metrics by applying Harrell’s concordance index (Harrell’s C-index) and Uno’s concordance (Uno’s C). The calibration performance was measured by the Brier score and plots.

Results

Of the 3216 C-STRIDE and 342 PKUFH participants, 411 (12.8%) and 25 (7.3%) experienced KRT with mean follow-up periods of 4.45 and 3.37 years, respectively. The features included in the PKU-CKD model were age, gender, estimated glomerular filtration rate (eGFR), urinary albumin–creatinine ratio (UACR), albumin, hemoglobin, medical history of type 2 diabetes mellitus (T2DM), and hypertension. In the test dataset, the values of the Cox model for Harrell’s C-index, Uno’s C-index, and Brier score were 0.834, 0.833, and 0.065, respectively. The XGBoost algorithm values for these metrics were 0.826, 0.825, and 0.066, respectively. The SSVM model yielded values of 0.748, 0.747, and 0.070, respectively, for the above parameters. The comparative analysis revealed no significant difference between XGBoost and Cox, in terms of Harrell’s C, Uno’s C, and the Brier score (p = 0.186, 0.213, and 0.41, respectively) in the test dataset. The SSVM model was significantly inferior to the previous two models (p < 0.001), in terms of discrimination and calibration. The validation dataset showed that XGBoost was superior to Cox, regarding Harrell’s C, Uno’s C, and the Brier score (p = 0.003, 0.027, and 0.032, respectively), while Cox and SSVM were almost identical concerning these three parameters (p = 0.102, 0.092, and 0.048, respectively).

Conclusions

We developed and validated a new ESKD risk prediction model for patients with CKD, employing commonly measured indicators in clinical practice, and its overall performance was satisfactory. The conventional Cox regression and certain ML models exhibited equal accuracy in predicting the course of CKD.

Schlagwörter

Stichwörter der Autor:innen

chronic kidney diseasemachine learningprediction modelprogression

Autor:innen und Institutionen

  • Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China.
  • Institute of Nephrology, Peking University, Beijing 100034, China.
  • Key Laboratory of Renal Disease, National Health Commission of China, Beijing 100034, China.
  • Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing 100034, China.
  • Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing 100034, China.
  • National Institute of Health Data Science at Peking University, Beijing 100191, China.

ORCID-Profile: Miao Hui, Jinwei Wang, Li Yang

Förderung

  • National Key R&amp;D Program of the Ministry of Science and Technology of China
  • National Natural Science Foundation of China
  • Chinese Scientific and Technical Innovation Project 2030
  • University of Michigan Health System–Peking University Health Science Center Joint Institute for Translational and Clinical Research
  • CAMS Innovation Fund for Medical Sciences
  • PKU-Baidu Fund
  • Non-profit Central Research Institute
  • National Key Research and Development Program of China

Zitieren

APA

Hui, M., Ma, J., Yang, H., Gao, B., Wang, F., Wang, J., Lv, J., Zhang, L., Yang, L., & Zhao, M. (2023). ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study. Journal of Clinical Medicine, 12(4), 1504. https://doi.org/10.3390/jcm12041504

Vancouver

Hui M, Ma J, Yang H, Gao B, Wang F, Wang J, et al. ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study. Journal of Clinical Medicine. 2023;12(4):1504. doi:10.3390/jcm12041504

BibTeX
@article{Hui2023,
  author = {Hui, Miao and Ma, Jun and Yang, Hongyu and Gao, Bixia and Wang, Fang and Wang, Jinwei and Lv, Jicheng and Zhang, Luxia and Yang, Li and Zhao, Minghui},
  title = {ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {1504},
  doi = {10.3390/jcm12041504}
}
Kostenlos starten →